NCT00033813View on ClinicalTrials.gov

KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2006

Conditions
Muscular Dystrophy, Duchenne
Interventions
DRUG

Oxatomide (tinset)

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

All Listed Sponsors
lead

Cooperative International Neuromuscular Research Group

NETWORK

NCT00033813 - KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter